Company Overview

Development Stage

About the Company

百奥赛图江苏基因生物技术有限公司(后简称“公司”)成立于2014年,系北京百奥赛图基因生物技术有限公司的全资子公司。成立至今,公司逐渐完成了从纯技术服务公司向以新药合作开发为主的生物技术公司转变。在全人抗体系列小鼠模型RenMab、RenLite、RenNano基础上,百奥赛图打造了一个包括单细胞抗体发现技术在内的快速高效的抗体开发平台,同时依托公司强大的基因编辑模型制备平台、规模化的动物繁殖与供应平台、高效率的动物体内体外药效评价平台,形成了从靶点验证、全人抗体的快速开发及动物体内外药理药效评价到IND临床申报的抗体药物一站式研发体系。 目前,公司已有员工400余人,核心技术团队由沈月雷博士带领具有多年模式动物规模化生产和药物筛选服务经验的多名海外留学和专业技能博士、硕士组成,模式动物制备和相关研究方面拥有丰富的实践经验和技术积累,并前后取得了“实验动物生产/使用许可证”、“动物防疫条件合格证”、“出口动物及非食用性动物产品生产、加工、存放企业和注册证”、“江苏省科技型中小企业”和“江苏省民营科技企业”“江苏省高新技术企业”等多项资质和荣誉。 公司将继续扩建二期和三期工程,届时将发展成为员工达3,000人的企业,成为中国*大的模式动物研发与供应基地。形成以模式动物与疾病模型为依托,国内外医药企业研发中心为纽带,贯穿生产与销售的的医药产业集群,极大促进我国生物医药研发进度,有效助力江苏经济的突飞猛进,进一步夯实江苏生物医药研发的产业基础。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (5 open positions)

Manage
Note: How fast is hiring at 百奥赛图江苏基因生物技术有限公司 growing? 2026: 6 openings (up 20%), 2025: 5 openings (up 400%), 2024: 1 openings (down 97%), 2023: 29 openings (up 190%), 2022: 10 openings (down 71%), 2021: 34 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2023 — 2 more jobs than 2022
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 百奥赛图江苏基因生物技术有限公司 growing? Doctorate recruitment over the years: 2023: 5 openings (up 190%), 2022: 3 openings (down 71%).

— What Are the Salaries Like? (11 records)

Manage
salary range: 4.5K - 50K, 90.9% of roles pay ¥6-50K
Note: salary statistics are based on 11 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 百奥赛图江苏基因生物技术有限公司?90.9% of positions earn 6-50K, Undergraduate salary: ¥。质量管理类 average salary ¥7.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 质量管理类
    45.5% of total 45.5%
  • 工厂生产类
    27.3% of total 27.3%
  • 医疗卫生/美容保健类
    18.2% of total 18.2%
  • 生物/制药/化工/环保类
    18.2% of total 18.2%

Education

  • 本科
    63.6% of total 63.6%
  • 大专
    18.2% of total 18.2%
  • 高中
    9.1% of total 9.1%
  • 不限
    9.1% of total 9.1%

Experience

  • 不限
    72.7% of total 72.7%
  • 1-3年
    27.3% of total 27.3%
View Detailed Analysis

What does 百奥赛图江苏基因生物技术有限公司 require? Who is 百奥赛图江苏基因生物技术有限公司 hiring? recruitment: 质量管理类占比最多占45.5%,其次是工厂生产类占27.3%. What education can get in at ? 本科占比最多占63.6%,其次是大专占18.2%. Work experience required at ? 不限占比最多占72.7%,其次是1-3年占27.3%. Where are the job locations at ? 南通占比最多占90.9%,其次是北京占9.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,111.1111万(元)
Legal Representative: 沈月雷
Date Established:
Credit Code: 91320684321315871C
Registered Address: 南通市海门区临江新区生物医药科创园B10楼

Partners & Suppliers

百奥赛图为君实生物提供RenMab小鼠平台用于抗体发现 Source
合作客户 药物研发合作
百奥赛图与北京大学合作研究基因编辑技术 Source
合作客户 高校研究院合作
百奥赛图为辉瑞提供基因编辑小鼠模型用于药物研发 Source
合作客户 药物研发合作
百奥赛图采购维通达的实验动物饲料和垫料 Source
供应商 上游试剂耗材
百奥赛图采购碧云天的分子生物学试剂 Source
供应商 上游试剂耗材

People who follow this company also follow

Competitors (Similar Companies)

“An international biopharmaceutical company driven by innovative techno”
医药 医药服务 CRO 临床研究
制药/药业 抗生素 生物制剂 生命科学
“Helping partners successfully develop new drugs, reducing R&D costs an”
生物医药 医药工业 基因工程 兽药/兽用药品
“Health for Humanity, Creating a Better Future Together”
“一家拥有70余年辉煌历史的制药企业”
“南通润丰石油化工有限公司是一家专业从事石油、化工产品贸易的综合性石化公司。”
制药/药业 维生素 医药 大健康
电力 环网柜 成套设备 生产
“专注于为食品、保健医药领域提供营养强化、补充和治疗解决方案的专业供应商”
医药 生物医药 医药工业 抗生素
研究院/研究所 科研机构 合成生物学 合成生物
生物科技/生物工程 医药 生物医药 医药中间体
广告 广告营销 咨询 医药市场营销

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates